A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic constipation in patients with Parkinson disease A randomized controlled study comparing lubiprostone and magnesium oxidefor treatment of chronic con ...
A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic constipation in patients with Parkinson disease - A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic constipation in patients with Parkinson disease A randomized controlled study comparing lubiprostone and magnesium oxidefor treatment of chronic con ...
Parkinson diseaseChronic constipation
Study drug group: A 12-week administration of lubiprostone 24 microrgrum (adjustable) twice daily after switching from magnesium oxide
Control group: Continuous administration of magnesium oxide at the same dosage regimen as before the enrollment Study drug group: A 12-week administration of lubiprostone24 microrgrum (adjustable) twice daily aft ...
A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic constipation in patients with Parkinson disease. -to evaluation by change of intestinal bacterial flora- A randomized controlled study comparing lubiprostone and magnesium oxidefor treatment of chronic con ...
A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic constipation in patients with Parkinson disease. -to evaluation by change of intestinal bacterial flora- - A randomized controlled study comparing lubiprostone and magnesium oxide for treatment of chronic constipation in patients with Parkinson disease. -to evaluation by change of intestinal bacterial flora- A randomized controlled study comparing lubiprostone and magnesium oxidefor treatment of chronic con ...
Parkinson diseaseChronic constipation
Study drug group: A 12-week administration of lubiprostone 24 microgrum (adjustable) twice daily after switching from magnesium oxide
Control group: Continuous administration of magnesium oxide at the same dosage regimen as before the enrollmen Study drug group: A 12-week administration of lubiprostone24 microgrum (adjustable) twice daily afte ...